|
Ewing Sarcoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 90 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2012" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental inf.....
Introduction GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2012" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ewing Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ewing Sarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Ewing Sarcoma 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by BRIC Nations 15 Clinical Trials by G7 Nations 16 Clinical Trials in G7 Nations by Trial Status 17 Clinical Trials by E7 Nations 18 Clinical Trials in E7 Nations by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Subjects Recruited Over a Period of Time 23 Prominent Sponsors 24 Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials 26 Prominent Drug Comparison 28 Clinical Trial Profiles 29 Clinical Trial Overview of Top Companies 29 Pfizer Inc. 29 Clinical Trial Overview of Pfizer Inc. 29 PharmaMar, S.A. 30 Clinical Trial Overview of PharmaMar, S.A. 30 Jennerex Biotherapeutics, Inc. 31 Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 31 Daiichi Sankyo, Inc. 32 Clinical Trial Overview of Daiichi Sankyo, Inc. 32 Oncolytics Biotech Inc. 33 Clinical Trial Overview of Oncolytics Biotech Inc. 33 Merck & Co., Inc. 34 Clinical Trial Overview of Merck & Co., Inc. 34 Eli Lilly and Company 35 Clinical Trial Overview of Eli Lilly and Company 35 Amgen Inc. 36 Clinical Trial Overview of Amgen Inc. 36 Genzyme Corporation 37 Clinical Trial Overview of Genzyme Corporation 37 Clinical Trial Overview of Top Universities / Institutes / Hospitals 38 Stanford University 38 Clinical Trial Overview of Stanford University 38 The University of Texas M. D. Anderson Cancer Center 39 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 39 St. Jude Children’s Research Hospital, Inc. 40 Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc. 40 Emory University 41 Clinical Trial Overview of Emory University 41 University of Munster 42 Clinical Trial Overview of University of Munster 42 City of Hope National Medical Center 43 Clinical Trial Overview of City of Hope National Medical Center 43 Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 44 Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 44 Sarcoma Alliance for Research through Collaboration 45 Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 45 St. Orsola Hospital 46 Clinical Trial Overview of St. Orsola Hospital 46 Institut Curie 47 Clinical Trial Overview of Institut Curie 47 Mayo Clinic 48 Clinical Trial Overview of Mayo Clinic 48 Institut Gustave Roussy 49 Clinical Trial Overview of Institut Gustave Roussy 49 Memorial Sloan Kettering Cancer Center 50 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 50 Fred Hutchinson Cancer Research Center 51 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 51 National Cancer Center 52 Clinical Trial Overview of National Cancer Center 52 Five Key Clinical Profiles 53 Appendix 87 Abbreviations 87 Definitions 87 Research Methodology 88 Secondary Research 88 About GlobalData 89 Contact Us 89 Disclaimer 89 Source 90 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Ewing Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 Ewing Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Ewing Sarcoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Ewing Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13 Ewing Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14 Ewing Sarcoma Therapeutics Clinical Trials, BRIC Countries, 2012* 15 Ewing Sarcoma Therapeutics Clinical Trials, G7 Countries, 2012* 16 Ewing Sarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17 Ewing Sarcoma Therapeutics Clinical Trials, E7 Countries, 2012* 18 Ewing Sarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22 Ewing Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Ewing Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25 Ewing Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27 Ewing Sarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 29 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaMar, S.A., 2012* 30 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012* 31 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012* 32 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2012* 33 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 34 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 35 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 36 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 37 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 38 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 39 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2012* 40 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 41 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2012* 42 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 43 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2012* 44 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2012* 45 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2012* 46 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2012* 47 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 48 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012* 49 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 50 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 51 Ewing Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2012* 52 List of Figures Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Ewing Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 Ewing Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Ewing Sarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 Ewing Sarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14 Ewing Sarcoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 16 Ewing Sarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17 Ewing Sarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21 Ewing Sarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22 Ewing Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23 Ewing Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24 Ewing Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26 Ewing Sarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28 GlobalData Methodology 88 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
